Bio-Equity 2025

Sebastien Stoitzner will be attending BioEquity

Bioequity 2025 GenSearch
We are pleased to announce that Sebastien Stoitzner will be attending BioEquity in Bruges this May. As a key figure in our organisation’s commitment to growth and innovation within the Life Sciences sector, Sebastien’s presence at this renowned conference underlines our dedication to staying at the forefront of industry developments.
Read more “Bio-Equity 2025”

Exploring the Future of Cell and Gene Therapies at Our HealthTech Leadership Dinner in Basel

We had the pleasure of co-hosting our #HealthTech Dinner in Basel with our partners at PwC Switzerland—an evening dedicated to exploring the evolving future of cell and gene therapies.

A heartfelt thank you to our guest speakers, Joshi Venugopal (Novartis Gene Therapies & Rare Diseases) and Gunther Busam (Orchard Therapeutics – U.S.), for their thought-provoking contributions.

Read more “Exploring the Future of Cell and Gene Therapies at Our HealthTech Leadership Dinner in Basel”